Previous 10 | Next 10 |
home / stock / acb / acb articles
Irwin Simon, a chairman and CEO of the largest Canadian cannabis company in the world, Tilray Brands (NASDAQ: TLRY), recently took a business and p...
German lawmakers are expecting a recently revised version of the marijuana legalization measure to bring about the long-awaited policy change in th...
Over the years, Israel has grown into an international giant in the cannabis industry. Recent regulatory reforms approved by the Israeli Ministry o...
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. Wynn Resorts repo...
Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported better-than-expected third-qu...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial and operational results for the second quarter of fiscal year 2024, ending Se...
Canada's leading cannabis producers are adapting to industry challenges by diversifying their cultivation to include vegetables, fruits an...
Canada's cannabis industry is about to hit C$6 billion (nearly $4.4 billion) in retail sales. In its latest report, analysis firm Z&a...
Two cannabis giants each closed their respective funding deals on Tuesday. Canadian Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) closed ...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- When it comes to investing in the legal marijuana industry, they don't call it the "green rush" for nothing. Many analysts are projecting massive growth for the cannabis industry. New Frontier, a Washington D.C.-based cannabis research firm, expects total U.S. legal cannabis s...
2024-07-18 05:30:00 ET To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell of its former self. Instead of acquiring large cannabis compani...
The marijuana industry has been significantly hindered by Section 280E of the IRS Code , which prevents businesses dealing with substances listed in Schedules 1 and 2 of the Controlled Substances Act (CSA) from deducting regular business expenses. Although Section 280E affects federal deductio...